Simulations for experiments: Bayer-backed startup lands $20M to test out its tech
How do you get the attention of Big Pharma when you’re a small biotech startup working out of Budapest, Hungary?
For Szabolcs Nagy and his co-founders at Turbine, the golden ticket came through Bayer’s grant program for digital health, G4A, for which the company was selected a few years back.
“We roamed around the building and sort of just knocked on a whole bunch of doors after a lot of introductions,” Nagy told Endpoints News.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,900+ biopharma pros reading Endpoints daily — and it's free.